Large vessel vasculitis occurs in a subgroup of patients with Behçet's disease who are at high risk for disease-related morbidity and mortality. Recognition of patients at risk, early detection of vasculitis, and aggressive treatment are essential for optimal care of these patients. We review the expanding knowledge on large vessel problems in Behçet's disease, highlighting recent contributions.
Vasculo-Behçet patients are at risk for multiple vessel-related complications including thromboses, stenoses, occlusions, and aneurysms. The primary reason for clot seems to be an inflammatory process in the vessel wall. Less invasive endovascular procedures are increasingly used to treat aneurysms in Behçet patients.
Because of earlier recognition, aggressive medical treatment, and novel surgical procedures, the morbidity and mortality of large vessel vasculitis in Behçet's disease are improving.
aMayo Clinic College of Medicine, Jacksonville, Florida, USA
bInnsbruck Medical University, Innsbruck, Austria
cCerrahpaşa Faculty of Medicine, University of Istanbul, Istanbul, Turkey
Correspondence to Kenneth T. Calamia, MD, Associate Professor of Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32225, USA Tel: +1 904 953 2062; fax: +1 904 953 0665; e-mail: firstname.lastname@example.org